Alexandra Karpman is the Head of Product at Subsense, with over 11 years of experience in brain-computer interface (BCI) development and 6 years in biomedical product management. She holds a master’s degree in Neuroscience, focused on neurorehabilitation and restoring motor impairment after stroke. Alexandra began her career as a neuroscientist in startups developing products for industries like pharmaceutical, banking, and marketing. In 2022, Alexandra joined Subsense as Head of Neuroscience, helping shape the company’s vision, roadmap, and scientific advisory board. A year later, as Head of Product, she established partnerships with experts from institutions like UCSC, Harvard, Stanford, and ETH Zurich from scratch and secured seed funding, driving Subsense’s growth. Her expertise spans product vision, market strategy, and managing cross-functional teams. At Subsense, Alexandra applies her deep experience in BCI, healthcare, and startups to advance non-surgical brain-computer interface technologies.
Dr. Scott Meek is the Head of R&D at Subsense and has spent the last 20 years developing new materials and sensors in academia, government labs, and biotech startups. After a B.A. in Chemistry from Dartmouth College, Dr. Meek completed his Ph.D. in Organic Chemistry at MIT in the research group of Tim Swager. His doctoral research focused on the design and synthesis of a new class of near-infrared fluorescent probes to detect beta-amyloid plaques. He moved on to Sandia National Labs as a postdoctoral fellow where he developed new nanoporous materials for gas and radiation sensing applications. At Subsense, he is delighted to bring together all of his experience in chemistry, materials science, multicomponent medical device, and product development to build the ultimate biosensor.
Dr. Uri Magaram is an Experimental Applications Scientist at Subsense, focusing on developing non-invasive, nanoparticle-based brain-computer interfaces. He earned his B.A. in Integrated Science and Mathematics from Northwestern University, where he conducted in vivo and slice electrophysiology research in zebrafish and mice under Drs. Indira Raman and David McLean. This experience deepened his passion for neuroscience, leading him to pursue a Ph.D. in Neurosciences at the University of California, San Diego, in Dr. Sreekanth Chalasani's lab. At the Salk Institute for Biological Studies, Dr. Magaram advanced sonogenetics—a technique combining ultrasound and genetic engineering to control neural circuits—through comprehensive research from materials engineering to in vivo experiments in C. elegans and mice. He co-founded SonoBac, aiming to enhance biomanufacturing via sonogenetics, and served as Chief Scientific Officer for two years before joining Subsense to further his commitment to neurotechnology and brain research.
To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures.